Telehealth safe harbor: a call to action for health plans
By AMI PAREKH A little-noticed telehealth safe harbor provision tucked inside the One Big Beautiful…
Telehealth safe harbor: a call to action for health plans
By AMI PAREKH A little-noticed telehealth safe harbor provision tucked inside the One Big Beautiful Bill was a significant milestone in virtual care. Though it specifically addresses pre-deductible telehealth services in high-deductible health plans, the legislation has far wider implications for both care delivery and insurance design, especially in the commercial insurance market. In fact…
Positioning & Distribution Will Determine the Winning Healthcare AI Startups, Investor Says
In a crowded healthcare AI market, the winners will be those that control key leverage points — where data is created, workflows are streamlined and value is delivered across stakeholders. This will differentiate winning AI startups from incumbents and copycat competitors, said Morgan Cheatham, head of healthcare and life sciences at Breyer Capital. The post…
A Third of Employers Can’t Access Medical Claims Data from Vendors, Survey Finds
Many employers are struggling to access their medical claims data from vendors. However, those who do have access are more likely to implement strategies to combat healthcare costs. The post A Third of Employers Can’t Access Medical Claims Data from Vendors, Survey Finds appeared first on MedCity News.
FDA Nod for J&J’s Drug/Device Treatment Gives Bladder Cancer Patients Another Option
A Johnson & Johnson cancer treatment that can spare certain bladder cancer patients from the radical step of surgical removal of the organ now has FDA approval. J&J’s drug/device combination product, Inlexzo, came from its 2019 acquisition of Taris Biomedical. The post FDA Nod for J&J’s Drug/Device Treatment Gives Bladder Cancer Patients Another Option appeared…
How did investors react to IRA’s Drug Price Negotiation Program?
The Inflation Reduction Act (IRA) created the Medicare Drug Price Negotiation Program (DPNP). The aim of the program is to reduce the cost of pharmaceuticals for Medicare. A key question is how are investors viewing this policy and how is it impacting their investment decisions. A paper by Canestaro, Patterson and Campbell (2025) aimed to…
Community Health Workers Key to Health Net’s Equity Efforts
Executives of the California Medicaid insurer discuss the impact of new CalAIM benefits on the deployment of community health workers
The Hidden Cost of Healthcare AI: Why Premium Prices Don’t Equal Premium Results
Now is a good time for health systems to step back and ask some foundational questions instead of rushing into their next AI purchase. The post The Hidden Cost of Healthcare AI: Why Premium Prices Don’t Equal Premium Results appeared first on MedCity News.
Data-Driven Decisions: Unlocking Strategic Financial Performance in Healthcare
Data is not optional; it is essential to financial stability and strategic growth. The organizations that thrive will be those that use data to lead, not follow. The post Data-Driven Decisions: Unlocking Strategic Financial Performance in Healthcare appeared first on MedCity News.
About Half of Adults with ACA Marketplace Coverage are Small Business Owners, Employees, or Self-Employed
This analysis estimates that 48% of adults under age 65 with individual market coverage are either employed by a small business with fewer than 25 workers, self-employed entrepreneurs, or small business owners. Because the vast majority of this coverage is purchased through the Affordable Care Act (ACA) Marketplaces, changes to the ACA, including the expiration…
Lice Pose No Health Threat, Yet Some Parents Push Back on Rules To Allow Affected Kids in Class
Any evidence of lice was once a reason for immediate dismissal from school, not to return until the student’s head was lice-free. But what are known as “no-nit” policies have been dropped in favor of “nonexclusion” rules, prioritizing class time over any nuisance caused by parasites the size of sesame seeds. That leniency, of late,…
